This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Company News For Nov 2, 2017
by Zacks Equity Research
Companies in the news are: NYT,X,EA,EVHC
Envision Healthcare's (EVHC) Q3 Earnings Miss Expectations
by Zacks Equity Research
Envision Healthcare's (EVHC) third-quarter results were adversely impacted by hurricanes Harvey and Irma.
AET, EVHC, HCA Q3 Earnings: Here are the Key Predictions
by Zacks Equity Research
Third-quarter results of the Healthcare stocks are likely to be impacted by the noise around Affordable Care Act, industry-wide softness in volume, rising level of bad debt and higher expenses.
Will High Costs Dent Envision Healthcare (EVHC) Q3 Earnings?
by Zacks Equity Research
Envision Healthcare's (EVHC) third-quarter earnings are likely to see a drag from high expenses, partly offset by increased revenues from its physician services segment.
Envision Healthcare (EVHC) Looks Good: Stock Adds 10.9% in Session
by Zacks Equity Research
Envision Healthcare (EVHC) was a big mover last session, as the company saw its shares rise almost 11% on the day amid huge volumes.
Envision Healthcare Continues to Expand Physician Services
by Zacks Equity Research
Envision Healthcare's (EVHC) numerous acquisitions and management changes are aimed at growing its physician services segment.
Envision Healthcare: Is EVHC a Good Pick for Value Investors?
by Zacks Equity Research
Envision Healthcare Corporation (EVHC) appears to be a good choice for value investors right now, given its favorable P/E and P/S metrics.
Envision Healthcare Makes Organizational Changes, Here's Why
by Zacks Equity Research
Envision Healthcare (EVHC) rejigs top management and announces share buyback as it realigns business.
Why Is Envision Healthcare (EVHC) Down 11.4% Since the Last Earnings Report?
by Zacks Equity Research
Envision Healthcare (EVHC) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Envision Healthcare Hurt by High Debt, Increasing Expenses
by Zacks Equity Research
Envision Healthcare's (EVHC) increasing debt and expenses continue to hurt. Further guidance cut by the company is concerning.
Envision Healthcare (EVHC) Q2 Earnings Beat, '17 View Cut
by Zacks Equity Research
Envision Healthcare's (EVHC) strong second-quarter earnings were driven by revenue growth in the Physician Services segment, partly offset by an increase in operating expenses.
Envision Healthcare (EVHC) Q2 Earnings Beat, Revenues Miss
by Zacks Equity Research
Envision Healthcare's (EVHC) second-quarter results were positively impacted by strong Physician Services segment.
Will Expenses Hit Envision Healthcare (EVHC) Q2 Earnings?
by Zacks Equity Research
Envision Healthcare's (EVHC) second-quarter earnings may suffer from high operating cost and low revenues from the ambulatory service unit.
Envision Healthcare Rallies on Infinity Healthcare Buyout
by Zacks Equity Research
Envision Healthcare Corporation (EVHC) recently announced that Envision Physician Services has acquired Infinity Healthcare, a multi-specialty physician group practice.
Envision Healthcare (EVHC) Acquires Anesthesia Associates
by Zacks Equity Research
Envision Healthcare Corporation (EVHC), recently announced that it has acquired Connecticut based anesthesia physician group practice, Anesthesia Associates of New London, P.C.
Why You Should Avoid Envision Healthcare (EVHC) Stock Now
by Zacks Equity Research
Investors' pessimism about Envision Healthcare (EVHC) has stemmed from the decline in 2017 earnings guidance, following first-quarter results.
Envision (EVHC) Acquires Gwinnett Emergency Specialists
by Zacks Equity Research
Envision Healthcare Corporation (EVHC) announced the acquisition of Gwinnett Emergency Specialists, P.C.
Envision (EVHC) Teams Up with Lyft to Focus on Transportation
by Zacks Equity Research
Envision Healthcare Corporation (EVHC) recently announced that it has teamed up with on-demand transportation service provider Lyft.
Should You Get Rid of Envision Healthcare (EVHC) Now?
by Zacks Equity Research
It may not be a good decision to keep Envision Healthcare (EVHC) stock in your portfolio anymore, at least if you don???t have a long time horizon to wait.
athenahealth (ATHN) Beats on Q4 Earnings, Misses Revenues
by Zacks Equity Research
athenahealth (ATHN) reported adjusted earnings of 42 cents per share, which beat the Zacks Consensus Estimate of 27 cents.
PerkinElmer (PKI) Misses Q4 Earnings & Revenue Estimates
by Zacks Equity Research
Waltham, MA-based PerkinElmer Inc (PKI) reported fourth-quarter 2016 earnings of 83 cents per share missing the Zacks Consensus Estimate of 86 cents
Cerner (CERN): What's in the Cards this Earnings Season?
by Zacks Equity Research
Cerner Corporation (CERN), a leading global provider of healthcare information technology solutions ("HCIT"), is set to report fourth-quarter 2016 results, after the closing bell on Feb 9.
Cardinal Health (CAH) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Cardinal Health (CAH), a global player in the healthcare services and products space, is set to report second-quarter fiscal 2017 results on Feb 7, before the bell.
Pacific Biosciences (PACB): What Awaits in Q4 Earnings?
by Zacks Equity Research
Pacific Biosciences of California Inc. (PACB) is scheduled to report fourth-quarter 2016 results on Feb 1, 2017.
Should Value Investors Choose Envision Healthcare (EVHC)?
by Zacks Equity Research
Value Investors might consider Envision Healthcare (EVHC) as a great pick on the back of its key value statistics.